Cornea / Ocular Surface

Sitting Down With... Claes Dohlman, Emeritus Professor of Ophthalmology, Harvard Medical School, USA.

Ascorbic acid testing could provide fast information on the severity of ocular injuries and postsurgical complications at the point-of-care

Three new pipeline therapies may offer relief to patients with ocular surface disease

Daniel Black discusses his experience with the ZEISS Cataract Suite markerless in the latest episode of In Conversation With…

5-year ATOM2 trial data confirms that 0.01% atropine is more effective at slowing myopia progression than 0.1% and 0.5% doses

A specialized imaging technique has revealed two previously unknown structures of the cornea

A new matrix therapy agent may promote corneal healing after epi-off CXL, improving patient comfort and recovery times

Highlights from Laboratoires Théa’s Satellite Education Program, “Ocular Surface: What’s New?” held on October 8, 2015, at the 7th EVER Congress, Nice, France.

What does analysis of the last five years of literature on endophthalmitis tell us about the priorities of the field, and the contributors to it?

The Light for Sight foundation provides ophthalmologists around the world with CXL training and ensures that no young patient must go without treatment